1) epidermal growth factor receptor
表皮生长因子受体
1.
Quantity research on epidermal growth factor in saliva and epidermal growth factor receptor in biopsy samples of recurrent aphthous ulcer patients;
复发性阿弗他溃疡患者唾液中表皮生长因子和病损区表皮生长因子受体的定量研究
2.
Expression and identification of the extracellular domain of human epidermal growth factor receptor type Ⅲ variant;
人表皮生长因子受体Ⅲ型突变体胞外区的克隆表达和鉴定
3.
Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells:a study in tumor-bearing nude mice;
RNAi技术抑制乳腺癌细胞表皮生长因子受体表达的在体实验研究
2) EGFR
表皮生长因子受体
1.
Detection of EGFR mRNA and LUNX mRNA in peripheral venous blood of the patients with NSCLC and its diagnostic value of micrometastasis;
外周血表皮生长因子受体和LUNX mRNA表达对肺癌微转移诊断的价值
2.
Expression of EGFR protein in oral lichen planus;
表皮生长因子受体在口腔扁平苔藓组织中的表达
3.
Expression and clinical significance of MMP-9 and EGFR in patients with non-small cell lung cancer;
基质金属蛋白酶-9和表皮生长因子受体在非小细胞肺癌中的表达及临床意义
3) Epidermal growth factor receptor(EGFR)
表皮生长因子受体
1.
Objective:The aim of this study was to investigate the expressions of Epidermal Growth Factor Receptor(EGFR),Matrix Metalloproteinase2 (MMP 2) and Matrix Metalloproteinase9 (MMP 9) in Chronic hepatocellular Disease(CHD)and Primary Hepatic Carcinoma (PHC).
目的 :研究慢性肝病 ( CHD)与原发性肝癌 ( PHC)中表皮生长因子受体 ( EGFR)、基质金属蛋白酶 2( MMP2 )、基质金属蛋白酶 9( MMP9)的表达并进行比较。
2.
Objective:To explore the expression of the epidermal growth factor receptor(EGFR)mRNA and vascular endothelial growth factor(VEGF)mRNA in ovarian carcinoma and its significance.
目的:探讨表皮生长因子受体(epidermal growth factor receptor,EGFR)基因和血管内皮生长因子(vascular endo-thelial growth factor,VEGF)基因mRNA在卵巢癌组织中的表达状况及临床意义。
3.
Objective: To detect the content of epidermal growth factor receptor(EGFR) and small breast epithelial mucin(SBEM) in peripheral blood from patients with breast cancer ,evaluate the diagnostic value of EGFR and SBEM being micrometastasis makers of breast cancer.
目的:检测表皮生长因子受体(EGFR)及乳腺上皮粘蛋白(SBEM)在乳腺癌患者外周血中的表达,探讨二者作为乳腺癌微转移标志物的应用价值。
4) epidermal growth factor receptor (EGFR)
表皮生长因子受体
1.
Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.
表皮生长因子受体(EGFR)基因酪氨酸激酶域体细胞突变与非小细胞肺癌(NSCLC)患者对酪氨酸激酶抑制剂吉非替尼敏感性密切相关。
2.
The epidermal growth factor receptor (EGFR) provides a rational target for cancer therapy as it is commonly overexpressed in a variety of solid tumors, and its deregulation is correlated with resistance to chemotherapy and radiotherapy and a poor prognosis.
在许多肿瘤组织中均有表皮生长因子受体(epidermal growthfactor receptor,EGFR)的过表达,它的失调与肿瘤对化疗和放疗的耐受以及不良预后相关,为肿瘤的治疗提供了一个理想的分子靶点。
3.
The overexpression and inappropriate activation of epidermal growth factor receptor (EGFR) is thought to play an important role in many tumors, especially for the head and neck carcinomas with the overexpression rate of 80%—100%.
表皮生长因子受体(Epidermal Growth Factor Receptor，EGFR)的过度表达和不恰当激活被认为与多种肿瘤的发生发展密切相关，尤其在头颈部肿瘤中EGFR表达上调最普遍，约占80％-100％。
5) EGF-R
表皮生长因子受体
1.
EGF-R Expressions of Common Tongue Fur in Tongue Cancer Patients;
表皮生长因子受体在舌癌患者常见舌苔中的表达
2.
Methods DI, SPF, PI in 50 cases of and EGF-R level in 28 cases of leiomyoma were measured by FCM and in myometrium as control.
目的 探讨子宫肌瘤细胞增殖及与表皮生长因子受体 (EGF R)水平的关系。
3.
METHODS: The epidermal growth factor receptor mediated EGF-R targeting non-viral vector EGF-R ligand GE7 system was constructed.
[目的]研究表皮生长因子受体介导的靶向性非病毒载体GE7基因转移系统介导细胞周期调节基因p21~(WAF-1/CIPl)对体外培养的人脑胶质瘤细胞和裸鼠荷人脑胶质瘤模型的治疗效应。
补充资料：表皮生长因子受体
表皮生长因子受体
为膜受体酪氨酸激酶，因其上有受体分子而表现酶的活性。对其形成的调节机制尚不清楚。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条